SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 2

Effect of mometasone furoate nasal spray on the DNA of nasal mucosal cells

Erkan YURTCU
Seda TÜRKOĞLU BABAKURBAN
Özlem YILMAZ ÖZBEK
Hakan AKKAŞ
Erdinç AYDIN
Pages
339–345
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results could formthe basis of clinical trials involving treatment with different ICs over longer treatment periods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Allergic rhinitis (AR) is a respiratory disease caused by inflammation of the nasal mucosa.
📊
Key Findings & Data:Because DNA damagehas been linked to several chronic diseases, we hypothesize that use of ICs could cause DNA damage in nasal mucosa cells, leading tomucosal atrophy and septal perforation.Materials and methods: Sixty patients with moderate or severe AR were divided randomly into two groups.
💡
Conclusion & Impact:These results could formthe basis of clinical trials involving treatment with different ICs over longer treatment periods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Allergic rhinitis (AR) is a respiratory disease caused by inflammation of the nasal mucosa. Intranasal corticosteroids(ICs) are an effective treatment for AR; however, their use has been associated with atrophy in nasal mucosae. Because DNA damagehas been linked to several chronic diseases, we hypothesize that use of ICs could cause DNA damage in nasal mucosa cells, leading tomucosal atrophy and septal perforation.Materials and methods: Sixty patients with moderate or severe AR were divided randomly into two groups. Mometasone furoate (MF)and antihistamine tablets (desloratadine) were given to the study (IC) group. Physiologic saline and desloratadine were given to thecontrol ((serum physiologic (SP)) group. Nasal irrigation fluid was taken from patients before study commencement and after 4 weeksof treatment. The comet assay was applied to detect DNA damage in nasal mucosa cells.Results: Nineteen patients were excluded, leaving a study population of 41 patients (IC group: 17 patients; SP group: 24 patients).Genotoxic damage was evaluated by comet assay.Conclusion: Treatment with MF spray for 4 weeks does not cause DNA breaks within cells in the nasal mucosa. These results could formthe basis of clinical trials involving treatment with different ICs over longer treatment periods.

🔖

Cite This Article

YURTCU, E., BABAKURBAN, S. T., ÖZBEK, Ö. Y., AKKAŞ, H., AYDIN, E. (2022). Effect of mometasone furoate nasal spray on the DNA of nasal mucosal cells. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 2, 339–345. https://ajindex.com/articles/610197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: 147-334.
  2. Keleş N, Ilicali C, Değer K. The effects of different levels of air pollution on atopy and symptoms of allergic rhinitis. Am J Rhinol 1999; 13: 185-190.
  3. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86: 494-507.
  4. Cingi C, Songu M. Nasal steroid perspective: knowledge and attitudes. Eur Arch Otorhinolaryngol 2010; 267: 725-730.
  5. Kalyoncu AF, Demir AU, Ozcakar B, Bozkurt B, Artvinli M. Asthma and allergy in Turkish university students: two cross sectional surveys 5 years apart. Allergol Immunopathol (Madr) 2001; 29: 264-271.
  6. Ciprandi G, Pronzato C, Ricca V, Baqnasco M, Canonica GW. Evidence of ICAM-1 expression on nasal epithelial cells in acute rhinoconjunctivitis due to pollen exposure. J Allergy Clin Immunol 1994; 4: 738-746.
  7. Minshall E, Ghaffar O, Cameron L, O’Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS et al. Assessment by nasal biopsy after long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-654.
  8. Cervin A, Andersson M. Intranasal steroids and septum perforation – an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology 1998; 36: 128-132.
  9. Bende M, Mark J. Long-term effects of topical corticosteroids in the nose. J Laryngol Otol 1992; 106: 810-812.
  10. Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002; 22: 1458-1467.
  11. Cervin A, Hansson C, Greiff L, Andersson M. Nasal septal perforations during treatment with topical nasal glucocorticosteroids are generally not associated with contact allergy to steroids. ORL J Otorhinolaryngol Relat Spec 2003; 65: 103-105.
  12. Eweiss A, Dogheim Y, Hassab M, Tayel H, Hammad Z. VCAM1 and eosinophilia in diffuse sino-nasal polyps. Eur Arch Otorhinolaryngol 2009; 266: 377-383.
  13. Verret DJ, Marple BF. Effect of topical nasal steroid sprays on nasal mucosa and ciliary function. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 14-18.
  14. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Toqias A, Zuberbier T, Baena-Caqnani CE, Canonica GW, van Weel C. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63(Suppl 86): 8-160. do Amaral RJ, Pedrosa Cda S, Kochem MC, Silva KR, Aniceto M, Claudio-da-Silva C, Borojevic R,